DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Linifanib is an investigational drug.
There have been 11 clinical trials for Linifanib. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2010.
The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Adenocarcinoma, and Gastrointestinal Neoplasms. The leading clinical trial sponsors are Abbott, Genentech, Inc., and BioGene Pharmaceutical Ltd.
Recent Clinical Trials for Linifanib
|Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis||BioGene Pharmaceutical Ltd.||Phase 1/Phase 2|
|A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors||Abbott||Phase 1|
|A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.||Abbott||Phase 1|